This publication is unavailable to your account. If you have more privileged account please try to use it or contact with the institution connected to this digital library.
Potaczek, Joanna
2006
Praca doktorska
The invented path of synthesis started with the connection of chiral synthon - 4-(2,3-epoxypropyl)morpholine (2) to 8-bromotheophylline ( 1 ). The synthon was received m reaction of morpholine with enantiomers of epichlorohydrin. Connecting the epoxide derivative to C-7 position of methyloxanthine results in chiral oxazolopurine - 7-(morpholinomethyl)-6, 7-dihydrooxazolo[2,3-f]purine-2,4(1H,3.H)-dione (3). The subsequent reaction with ammonia gives the desired product-8-amino-7-[2-hydroxy 1-3-( morpholin-4 yl) propyl]theophylline (4). The proposed method let to obtain 77 and 79 percentage of ( +) and (-) enantiomers (4), respectively. The synthesis by using of another synthon - glycidyl p-toluenesulfonate does not succeed. The pharmacological tests revealed that the both enantiomers 8-amino-7-[2-hydroxyl-3(morpholin-4-yl)propyl]theophylline (4) exhibit hypothensive activity. lt has been shown that this activity is not linked with the affinity to adrenergic receptors nor spazmolitic activity. During the reaction of 8-bromotheophy lline (1) with 4-(2,3-epoxypropyl) morpholine (2) an interesting rearrangement occur: the obtained oxazolopurine (3)is transformed to an isomeric compound 7-(morpholino )-7 ,8-dihydro-6H-[ 1,3 ]oxazino [2,3-f]purine-2,4(1H,3H)-dione (5).
Kraków
2 - studia doktoranckie
farmakologia
Wydział Farmaceutyczny
Cegła, Marek
oai:dl.cm-uj.krakow.pl:1083
ZB-105320
pol; eng
tylko w bibliotece
Jun 26, 2023
Nov 21, 2012
3 112
0
http://dl.cm-uj.krakow.pl:8080/publication/1083
RDF
OAI-PMH
Kozaczek, Ewelina
Zygmunt, Małgorzata
Rapacz, Anna
Bednarski, Marek
Kubacka, Monika
Citation style: chicago-author-date iso690-author-date
This page uses 'cookies'. More information I understand